Ryali Sriram 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 15, 2021
Insider Transaction Report
Form 4
Ryali Sriram
Chief Financial Officer
Transactions
- Award
Common Stock
2021-03-12+16,250→ 18,152 total - Award
Stock Option (Right to Buy)
2021-03-12+97,500→ 97,500 totalExercise: $9.99Exp: 2031-03-11→ Common Stock (97,500 underlying)
Footnotes (3)
- [F1]Represents shares underlying Restricted Stock Units award that will vest in three equal annual installments measured from March 12, 2021.
- [F2]Includes 274 shares acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan on March 5, 2021.
- [F3]The option vests in equal monthly installments over 48 months measured from March 12, 2021 subject to Reporting Person's continuous service status as of each such date.